Andrew McCombie

Dr. Andrew McCombie

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
AMAndrew McCombie
Andrew McCombie
RMRoger T. Mulder
Roger T. Mulder
RGRichard Gearry
Richard Gearry
Psychotherapy may be a useful intervention for inflammatory bowel disease (IBD) patients. We systematically reviewed all randomized controlled trials that have been performed in psychotherapy for inflammatory bowel disease patients. Systematic searches were undertaken on 1 and 8 March, 2012 of studies of psychotherapy for IBD. Eighteen studies (19 papers) were included in this review. Psychotherapy was found to have minimal effect on measures of anxiety, depression, QOL and disease progression although shows promise in reducing pain, fatigue, relapse rate and hospitalisation, and improving medication adherence. It may also be cost effective. The effects of psychotherapy on IBD is mixed: future studies should determine whether patient screening or measuring different dependent variables improves outcomes and whether particular psychotherapies are superior over others.

1 January 2016 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
AMAndrew McCombie
Andrew McCombie
RGRichard Gearry
Richard Gearry
JAJane Andrews
Jane Andrews
RMRoger Mulder
Roger Mulder
AMAntonina Mikocka-Walus
Antonina Mikocka-Walus
Cognitive behavioral therapy may be useful for improving health-related quality of life (HRQOL) of at least some patients with inflammatory bowel disease (IBD), especially those with psychiatric comorbidities. However, cognitive behavioral therapy can be difficult to access. These difficulties can be overcome by computerized cognitive behavioral therapy (CCBT). This is a randomized controlled trial of a self-administered CCBT intervention for patients with IBD focused on improving HRQOL. It is hypothesized that CCBT completers will have an improved HRQOL relative to people not allocated to CCBT. Patients with IBD were randomly allocated to CCBT (n = 113) versus treatment as usual (n = 86). The IBD Questionnaire at 12 weeks after baseline was the primary outcome, while generic HRQOL, anxiety, depression, coping strategies, perceived stress, and IBD symptoms were secondary outcomes. Outcomes were also measured at 6 months after baseline. Predictors of dropout were also determined. Twenty-nine CCBT participants (25.7%) completed the CCBT. The IBD Questionnaire was significantly increased at 12 weeks in CCBT completers compared with treatment-as-usual patients (F = 6.38, P = 0.01). Short Form-12 mental score (F = 5.00, P = 0.03) was also significantly better in CCBT compared with treatment-as-usual patients at 12 weeks. These outcomes were not maintained at 6 months. The predictors of dropout were baseline depression, biological use, lower IBD Questionnaire scores, and not having steroids. Improvements at 12 weeks after baseline were not maintained at 6 months. Future research should aim to improve adherence rates. Moreover, CCBT may not work for patients with IBD with comorbid depression.

1 March 2013 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
AMAndrew McCombie
Andrew McCombie
RMRoger T. Mulder
Roger T. Mulder
RGRichard Gearry
Richard Gearry
Inflammatory bowel disease (IBD) can have a significant impact on psychological wellbeing and quality of life. How one responds to and copes with IBD may be an important determinant of psychological wellbeing. We aimed to systematically review all published literature regarding coping strategies of IBD patients. Ovid and Pubmed databases were searched over 6 months. All articles about coping strategies of IBD patients were included. Thirty-nine articles using twenty-two survey instruments were found, of which twenty-six were adult exclusive, eleven were children exclusive, and two had both adults and children. Two were interventional, four were longitudinal, and the rest were cross-sectional studies. Four studies were qualitative while the rest used quantitative measures. Variance in research designs and coping instruments led to inconsistent results. The most common theme was that emotion-focused coping was associated with worse psychological outcomes, while the effect of problem-focused coping was less consistently associated with better psychological outcomes. More longitudinal and interventional studies are needed to causally link coping strategies with psychological outcomes in IBD patients.

23 October 2019 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
AMAndrew McCombie
Andrew McCombie
RWRussell Walmsley
Russell Walmsley
MBMurray Barclay
Murray Barclay
CHChristine Ho
Christine Ho
TLTobias Langlotz
Tobias Langlotz
MSMichael Schultz
Michael Schultz
Providing timely follow-up care for patients with inflammatory bowel disease in remission is important but often difficult because of resource limitations. Using smartphones to communicate symptoms and biomarkers is a potential alternative. We aimed to compare outpatient management using 2 smartphone apps (IBDsmart for symptoms and IBDoc for fecal calprotectin monitoring) vs standard face-to-face care. We hypothesized noninferiority of quality of life and symptoms at 12 months plus a reduction in face-to-face appointments in the smartphone app group. Inflammatory bowel disease outpatients (previously seen more often than annually) were randomized to smartphone app or standard face-to-face care over 12 months. Quality of life and symptoms were measured quarterly for 12 months. Acceptability was measured for gastroenterologists and patients at 12 months. One hundred people (73 Crohn’s disease, 49 male, average age 35 years) consented and completed baseline questionnaires (50 in each group). Intention-to-treat and per-protocol analyses revealed noninferiority of quality of life and symptom scores at 12 months. Outpatient appointment numbers were reduced in smartphone app care (P < 0.001). There was no difference in number of surgical outpatient appointments or number of disease-related hospitalizations between groups. Adherence to IBDsmart (50% perfect adherence) was slightly better than adherence to IBDoc (30% perfect adherence). Good acceptability was reported among most gastroenterologists and patients. Remote symptom and fecal calprotectin monitoring is effective and acceptable. It also reduces the need for face-to-face outpatient appointments. Patients with mild-to-moderate disease who are not new diagnoses are ideal for this system. ACTRN12615000342516.

1 June 2015 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
AMAndrew McCombie
Andrew McCombie
RMRoger T. Mulder
Roger T. Mulder
RGRichard Gearry
Richard Gearry
Background. Inflammatory bowel disease (IBD) is associated with reduced physical and mental well-being. The first 6 months after diagnosis is an important time

11 February 2015 in Journal of Clinical Psychology in Medical Settings
Verified
Journal Article
Closed access
PDF file
AMAndrew McCombie
Andrew McCombie
RGRichard Gearry
Richard Gearry
JAJane Andrews
Jane Andrews
AMAntonina Mikocka-Walus
Antonina Mikocka-Walus
RMRoger Mulder
Roger Mulder